Association of the C825T polymorphism in the GNB3 gene with obesity and metabolic phenotypes in a Taiwanese population

The GNB3 C825T polymorphism as a pharmacogenetic marker in the treatment of hypertension, obesity, and depression

(2011) Stefanie Klenke et al.   Pharmacogenetics and Genomics

Chipping Away the ‘Missing Heritability’: GIANT Steps Forward in the Molecular Elucidation of Obesity – but Still Lots to Go

(2010) Johannes Hebebrand et al.   Obesity Facts

Recent progress in the genetics of common obesity

(2009) Ruth J. F. Loos   BRITISH JOURNAL OF CLINICAL PHARMACOLOGY

Gene-Gene Interactions Among Genetic Variants from Obesity Candidate Genes for Nonobese and Obese Populations in Type 2 Diabetes

(2009) Eugene Lin et al.   Genetic Testing and Molecular Biomarkers

A comparison of classification methods for predicting Chronic Fatigue Syndrome based on genetic data

(2009) Lung-Cheng Huang et al.   Journal of Translational Medicine

Association and interaction analyses of genetic variants in ADIPOQ, ENPP1, GHSR, PPAR  and TCF7L2 genes for diabetic nephropathy in a Taiwanese population with type 2 diabetes

(2009) L. S.-H. Wu et al.   NEPHROLOGY DIALYSIS TRANSPLANTATION

Weight loss and body fat reduction under sibutramine therapy in obesity with the C825T polymorphism in the GNB3 gene

(2009) Dun-Jen Hsiao et al.   Pharmacogenetics and Genomics

Interaction of serotonin-related genes affects short-term antidepressant response in major depressive disorder

(2009) Eugene Lin et al.   PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY

A Controlled Pharmacogenetic Trial of Sibutramine on Weight Loss and Body Composition in Obese or Overweight Adults

(2008) April B.M. Grudell et al.   GASTROENTEROLOGY

Global burden of obesity in 2005 and projections to 2030

(2008) T Kelly et al.   INTERNATIONAL JOURNAL OF OBESITY